bioRxivCell BiologyPreprint
Dual role of brain endothelial Gpr126 in blood-brain barrier development and ischemic stroke
N. Kakogiannos, A. A. Scalise, E. Martini, C. Maderna, S. Magni, G. S. Gullotta, M. G. Lampugnani, F. Iannelli, G. Beznusenko, A. Mironov, C. Cerutti, K. Bentley, A. Philippides, F. Zanardi, M. Bacigaluppi, G. Martino, E. Dejana, M. Giannotta
Abstract
The blood-brain barrier (BBB) acquires unique properties for regulation of the neuronal function during development. The genesis of the BBB coupled with angiogenesis is orchestrated by the Wnt/{beta}-catenin signaling pathway. Aside from the importance of Wnt/{beta}-catenin signaling, the molecular mechanisms that regulate these processes are poorly understood. Here, we identify the brain endothelial adhesion G-protein-coupled receptor Gpr126 as a novel target gene of Wnt/{beta}-catenin signaling that is required for postnatal BBB development, and its expression is detrimental for ischemic stroke in adults. We show that Gpr126 expression is high in mouse brain endothelium during BBB formation, but decreases in the adult. Inactivation of Gpr126 in postnatal endothelial cells results in vessel enlargement and impairs acquisition of the BBB characteristics, such as increased neurovascular permeability, and reduced basement membrane protein deposition and pericyte coverage. Mechanistically, Gpr126 is required during developmental angiogenesis to promote endothelial cell migration, acting via an interaction between Lrp1 and 3{beta}1-integrin, which couples vessel morphogenesis to BBB formation. Interestingly, in adult mice with an established BBB, the lack of Gpr126 expression in acute ischemic stroke is protective and coupled with reduced microglia activation, which contributes to an improved neurological outcome. These data identify Gpr126 as a promising therapeutic target to treat ischemic stroke.
- organism: mouse
- assay: spatial transcriptomics
- assay: imaging
- research focus: host-pathogen & immune response
- research focus: development & morphogenesis
- research focus: drug response / drug discovery
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- IL-1β disrupts blood-brain barrier development by inhibiting endothelial Wnt/β-catenin signaling
A. R. Fetsko, D. J. Sebo, … M. R. Taylor·bioRxiv·Dec 4, 2023
- Wnt/beta-catenin signaling regulates Vascular Endothelial Growth Factor (VEGF) receptors in central nervous system endothelial cells
Yanshu Wang, Ningyu Zhu, … Jeremy Nathans·bioRxiv·Sep 7, 2026
- Endothelial type I interferon signaling modulates the vascular response to ischemic brain injury
Mary Claire Tuohy, Ping‐Chang Kuo, … Dritan Agalliu·bioRxiv·Sep 9, 2025
- Wnt signaling mediates acquisition of blood-brain barrier properties in naïve endothelium derived from human pluripotent stem cells
Benjamin D. Gastfriend, Hideaki Nishihara, … Eric V Shusta·eLifePeer-reviewed·Nov 10, 2021
- Ligand-specific endothelial Notch signaling coordinates brain pericyte specification and expansion
Huaxing Zi, Chi Dang, … Jingjing Zhang·bioRxiv·Oct 9, 2026
- Canonical Wnt Signaling Suppresses Brain Endothelial Cell Transcytosis to Maintain Blood-Brain Barrier Integrity
Xavier du Maine, Chenghua Gu·bioRxiv·Mar 10, 2025